& Blannin, A
In recent years, there has been a significant increase in the number of patients being prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of medications used to manage both type 2 diabetes and obesity ( 1 4 )
Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Meanwhile, at the same time, the members successfully lost up to 11 pounds in 30 days and 17 pounds in 60 days at microdose dosages
Discuss with your provider how often to recheck thyroid function during GLP-1 initiation, and ensure levothyroxine timing is separated from any other medications that could interfere with absorption
GLP-1 receptor agonists, which are the class of medications that includes semaglutide and tirzepatide, work by mimicking this hormone
)
